Stock Price Movement and Market Context
On 9 December 2025, Chemfab Alkalis recorded its lowest price in the last 52 weeks at Rs.461.3. Despite this, the stock outperformed its sector by 0.53% on the day, showing a modest gain after two consecutive days of decline. However, the stock remains below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating sustained downward momentum.
In contrast, the broader market, represented by the Sensex, opened lower by 359.82 points and was trading at 84,615.16, down 0.57%. The Sensex remains close to its 52-week high of 86,159.02, just 1.82% away, and is trading above its 50-day moving average, which itself is above the 200-day moving average, signalling a generally bullish market environment. This divergence highlights Chemfab Alkalis’ underperformance relative to the broader market.
Financial Performance and Profitability Trends
Over the last year, Chemfab Alkalis’ stock price has declined by approximately 55.86%, while the Sensex has recorded a positive return of 3.82%. This stark contrast reflects the company’s financial difficulties and market challenges. The company’s operating profit has shown a negative compound annual growth rate of 6.47% over the past five years, indicating a prolonged period of subdued profitability.
The company’s recent quarterly results reveal further pressures. Net sales for the quarter stood at Rs.76.56 crores, reflecting a 12.3% reduction compared to the previous four-quarter average. Profit before tax (PBT) was reported at a loss of Rs.3.09 crores, representing a decline of 316.1% relative to the prior four-quarter average. Similarly, the net profit after tax (PAT) was a loss of Rs.2.01 crores, down 274.8% against the same benchmark. These figures mark the tenth consecutive quarter of negative results for Chemfab Alkalis.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Valuation and Capital Efficiency
Chemfab Alkalis’ return on capital employed (ROCE) stands at 1.8%, which is considered low relative to industry standards. The company’s enterprise value to capital employed ratio is 1.6, suggesting a valuation that is relatively expensive compared to its peers’ historical averages. This premium valuation persists despite the company’s subdued financial performance and shrinking profits, which have fallen by approximately 75.8% over the past year.
Notably, the company maintains a low average debt-to-equity ratio of 0.10 times, indicating limited leverage on its balance sheet. This conservative capital structure may provide some cushion but has not translated into improved market sentiment or stock performance.
Shareholding and Market Participation
Domestic mutual funds hold a minor stake of just 0.25% in Chemfab Alkalis. Given their capacity for detailed research and on-the-ground analysis, this limited exposure may reflect a cautious stance towards the company’s current valuation and business outlook. The stock’s underperformance is further emphasised by its comparison with the BSE500 index, which has generated a modest return of 0.21% over the last year, while Chemfab Alkalis has recorded a negative return of 55.86%.
Chemfab Alkalis or something better? Our SwitchER feature analyzes this micro-cap Commodity Chemicals stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Summary of Key Challenges
Chemfab Alkalis’ stock has been on a downward trajectory for the past year, culminating in the recent 52-week low of Rs.461.3. The company’s financial results have consistently reflected contraction, with declining net sales and losses reported over ten consecutive quarters. The subdued operating profit growth over five years and the significant fall in quarterly profits highlight ongoing difficulties in generating sustainable earnings.
Despite a low debt profile, the company’s valuation metrics suggest a premium relative to its peers, which may be difficult to justify given the current earnings profile. The limited participation by domestic mutual funds further underscores the cautious market stance towards the stock.
While the broader market continues to trade near record highs, Chemfab Alkalis remains an outlier with its pronounced underperformance. The stock’s position below all major moving averages indicates that the prevailing trend remains negative, with no immediate signs of reversal in the technical indicators.
Get 1 year of Weekly Picks FREE when you subscribe to MojoOne. Offer ends soon. Start Saving Now →
